GSK Shares Rise 2.3% on Q1 Earnings Beat and Raised Full-Year Profit Guidance

Gelonghui May 1 | GSK (GSK.US) rose 2.36% to $42.42. GSK's Q1 revenue was £7.36 billion, up 10% year-over-year on a constant currency basis, surpassing market expectations of £7.07 billion; earnings per share were 43.1 pence, higher than the expected 37.3 pence. GSK raised its full-year profit guidance, forecasting an 8% to 10% growth rate in adjusted earnings per share for 2024, up from the previous estimate of 6% to 9%; revenue growth is expected to reach the upper end of the 5% to 7% forecast range. The company is preparing to launch 12 new products starting in 2025.